The biotechnology market is entering a new growth phase, driven by the convergence of genomic science, artificial intelligence, and precision medicine.
The Chosun Ilbo on MSN
Pharmaceutical, Biotech Industries Avoid 100% Tariffs
Earlier, President Trump stated that companies without factories in the U.S. would face 100% tariffs on their pharmaceuticals ...
Health Biotech Limited (Health Biotech), a research and development-driven pharmaceutical company from India, successfully ...
Bharat Biotech launches Nucelion Therapeutics, a CRDMO in Hyderabad for advanced cell and gene therapy manufacturing and development.
Pfizer is suing Novo Nordisk following the Danish pharma's last-minute bid to acquire Metsera, which Pfizer called “reckless”.
Bharat Biotech expands into advanced biologics with Nucelion Therapeutics, a new CRDMO for cell and gene therapy ...
Health Biotech Limited, an Indian pharmaceutical company, successfully showcased its innovative products at CPHI Frankfurt 2025, a notable global pharmaceutical event. The company, celebrated for its ...
BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) is one of the most profitable biotech stocks to buy. Wells Fargo maintained a Buy ...
Biotech Viking Therapeutics has gained prominence over the past two years, but it could have plenty of upside left.
Investors want their money to grow in some shape, form, or fashion with every stock they buy. However, I understand that ...
Both companies are leaders in their niche with excellent growth prospects. They could deliver market-beating returns through 2031 and beyond. These are great picks with or without soaring inflation.
A report by GlobalData revealed that the biotech industry witnessed a 70.9% increase in total venture financing deal value.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results